August 26, 2025

FDA Begins Real-Time Reporting of Adverse Event Data

According to the FDA, the shift is one of many steps in the agency’s broader data modernization strategy to streamline all of its adverse event reporting systems and increase reporting frequency across all systems to identify safety signals faster.

Ophthalmology Management

August 17, 2025

FDA Affirms Safety of PFAS-Based Materials in Medical Devices

PFAS used in medical devices are different from the small-molecule PFAS that have been linked to environmental and health concerns.

Contact Lens Spectrum

May 23, 2024

New 3D Printing Method for Intraocular Lenses

Discover how a new stereolithography-based 3D printing method is advancing the prototyping of intraocular lenses, enhancing design flexibility and biocompatibility.

Conexiant

September 01, 2023

FOCUSING ON THE TARGET

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Contact Lens Spectrum

April 27, 2025

How to Increase Volume in the Space You Have

It's all about flow, says consultant Larry R. Brooks.

Ophthalmology Management

June 19, 2024

Specialties With Highest Unprofessional Behavior Reports

A recent study reveals that surgeons are most frequently reported for unprofessional behavior by coworkers, while pediatric-focused physicians are least likely to be reported.

Conexiant

January 14, 2025

Shortages Continue in Access to Ophthalmic Subspecialties in Rural Populations

Only 5.6% of surgeons practiced in rural areas, compared to 17.4% of patients residing rurally.

Conexiant

June 05, 2024

Noncompete Ban May Not Help Nonprofit Workers

Health care professionals welcome the FTC's new rule banning noncompete agreements but are concerned it may not protect those in nonprofit health care settings, potentially impacting most of the nation's medical professionals.

KFF Health News

December 13, 2024

Large Study Reveals Melanoma's Hidden Risks

Analysis of over 280,000 melanoma patients reveals these survivors face significantly elevated risks of developing 12 different types of second primary cancers, with the risk being particularly pronounced in younger patients and those with thicker tumors.

Conexiant